echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Pharmaceutical industry experts gather in Taizhou, Zhejiang province to monitor the trend of the industry

    Pharmaceutical industry experts gather in Taizhou, Zhejiang province to monitor the trend of the industry

    • Last Update: 2017-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2017 China (Taizhou, Zhejiang) pharmaceutical industry development and supervision Summit Forum was opened in Taizhou It is reported that the purpose of this forum is to "form consensus" and "combine production with learning", analyze and discuss the international regulatory situation of the pharmaceutical industry, keep track of the trend of the pharmaceutical industry, strengthen technical exchanges, strive to form a consensus on drug regulation and development, and help the pharmaceutical industry to develop continuously and healthily (photographed by Lin Liping, mayor of Taizhou Zhang Bing, at the forum) on the 17th, 2017 China (Taizhou, Zhejiang) pharmaceutical industry development and supervision Summit Forum officially opened in Taizhou, Zhejiang Province The theme of this forum is "continuous improvement and fission development" Topics include reform policy and development, strategic scientific and technological innovation and fission development Through analyzing the international regulatory situation, monitoring the trend of the pharmaceutical industry, promoting the new drug policy, strengthening technical exchanges, and studying the development strategies of the pharmaceutical industry under the international background of drug registration, we will strive to reach consensus on drug regulation and development, and create a domestic pharmaceutical industry brand forum Taizhou is located in the central coastal area of Zhejiang Province, with a long history It is one of the developed areas of China's pharmaceutical and chemical industry, with more than 100 medical and chemical enterprises Taizhou pharmaceutical industry and chemical API production play an important role in the same industry in China It has a national chemical API export base and has considerable competitiveness in the international market Zhang Bing, mayor of Taizhou, said in a speech at the forum that the pharmaceutical industry is an important pillar industry in Taizhou at present and one of the five hundred billion leading industries to be vigorously cultivated in the future The pace of industrial transformation and upgrading has been accelerating, which has the characteristics of large-scale industry, high industrial agglomeration and strong R & D and innovation capabilities In 2016, the total value of Taizhou's pharmaceutical industry reached 33.679 billion yuan, accounting for 8% of the enterprises above Designated Size; from January to June this year, the added value of the pharmaceutical enterprises above Designated Size in the city was 4.721 billion yuan, the export delivery value was 6.381 billion yuan, and the profit was 1.69 billion yuan, accounting for 9.2%, 10.96% and 13.7% of the enterprises above Designated Size in Taizhou respectively "Taizhou will strive to promote the transformation of modern pharmaceutical manufacturing mode, accelerate the cultivation of a number of large pharmaceutical groups with international influence, further improve the pharmaceutical industry structure and green intelligent manufacturing system, constantly enhance the level of industrial internationalization and innovation ability, and strive to build Taizhou into a" green pharmaceutical capital of China ", said Zhang Bing It is reported that the purpose of this forum is to "form consensus" and "combine production with learning", analyze and discuss the international regulatory situation of the pharmaceutical industry, keep track of the trend of the pharmaceutical industry, strengthen technical exchanges, strive to form a consensus on drug regulation and development, and help the pharmaceutical industry to develop continuously and healthily At the same time, it will promote the R & D, registration and supervision of Taizhou enterprises to gradually integrate with the international rules, open a new journey for the development of Taizhou pharmaceutical industry, and make a new and great contribution to Taizhou's "manufacturing capital" Lai maode, President of China Pharmaceutical University, said that he expects that through the successful holding of this forum, he will be able to base himself on the international forefront, look at the future development trend, devote himself to improving the core competitiveness of the pharmaceutical industry, offer advice and suggestions, gather wisdom, and contribute to deepening the reform of the medical and health system, accelerating the upgrading of the pharmaceutical industry, and building a healthy China Former title: experts of pharmaceutical industry gather in Taizhou, Zhejiang Province to talk about the new development of green pharmaceutical capital
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.